Table 1.

Demographics, primary and liver metastatic tumors of 27 patients with small intestine neuroendocrine tumor

Case#	age	Gender	Primary tumor grade	Months from initial diagnosis to liver resection	Months from primary resection to liver resection	Number of liver tumor	Size (cm)	Liver tumor grade	PFS (months) from liver resection	outcome	Overall Survival (months) after initial diagnosis
1	58	M	NA	60	60	5	0.3–3.2	G1, G2	38	AWD	194
2	61	F	NA	38	38	11	1.2–5.5	G2	14	DOD	52
3	59	F	G1	0	0	4	0.2–2.0	G1, G2	37	DOD	58
4	67	F	G1	0	0	3	0.5–3.4	G1	No progression	AWND	58
5	55	M	NA	59	59	5	0.5–1.5	G1	No progression	AWND	106
6	60	F	G1	1	0	2	0.5–1.0	G2	7	AWD	70
7	60	M	G1	0	0	4	0.8–5.0	G1, G2	Unknown	Alive	23
8	58	M	G1	6	0	5	0.5–2.5	G1, G2	No progression	AWD	27
9	61	F	G1	78	78	13	0.2–2.6	G1, G2, G3	8	AWD	97
10	61	F	G1	30	30	7	0.4–0.8	G1	No progression	AWD	60
11	71	M	G1	24	24	7	0.1–0.4	G2, G3	7	DOD	40
12	75	M	G1	4	0	12	0.4–2.5	G1, G2, G3	7	AWD	21
13	44	M	G2	27	27	8	0.3–1.7	G1, G2, G3	6	AWD	48
14	62	F	G1	2	0	17	0.3–6.2	G1, G2	No progression	AWD	17
15	72	F	NA	17	17	12	0.1–2.6	G1	No progression	AWD	36
16	63	M	G1	68	68	5	0.7–3.1	G1, G2, G3	9	AWD	81
17	54	F	NA	4	4	9	0.3–1.5	G1	No progression	AWD	15
18	61	M	G2	7	0	3	0.9–1.4	G2	8	AWD	31
19	49	F	G1	2	0	2	2.0–2.5	G1, G2	No progression	AWND	24
20	55	F	G1	5	0	3	1.0–2.0	G1	No progression	AWND	23
21	71	M	G1	106	106	7	0.5–1.7	G1, G2, G3	Unknown	Alive	110
22	60	F	G2	13	13	3	0.6–3.2	G2, G3	Unknown	Alive	16
23	59	F	G1	1	0	5	0.8–5.4	G1	Unknown	Alive	3
24	54	F	NA	8	NA	14	0.7–3.5	G1	Unknown	Alive	10
25	70	F	NA	16	16	7	0.5–3.8	G2, G3	Unknown	Alive	25
26	65	F	G1	2	0	3	0.5–5.6	G1	Unknown	Alive	3
27	20	F	G1	0	0	12	0.3–1.8	G1	Unknown	Alive	2

NA: not available; AWD: alive with disease; DOD: die of disease; AWND: alive with no disease.